Biotechnology is one of the most promising manufacturing sectors of the 21st century. Intensive research has led to the development and production of new drugs that greatly contribute to quality of life. IDT Biologika is a medium-sized company founded over 95 years ago in Dessau, Germany, where it is still headquartered. The company now operates subsidiaries worldwide to continue its mission of improving the health of humans and animals through its products and services. IDT uses biotechnology to manufacture vaccines and pharmaceuticals for national and international markets.
Company sites in Germany include the BioPharmaPark in Dessau-Rosslau and the Riems district of Greifswald. IDT's Animal Health business is marketed internationally from its offices in Denmark, the Netherlands, France, Spain, Poland, China and Canada. In the United States, IDT Corporation operates a production site for clinical test samples in Rockville, Maryland. In Canada, IDT Biologika subsidiary Gallant Custom Laboratories manufactures autogenous vaccines. The same vaccines are produced by the recently acquired IDT subsidiary in the United Kingdom, Ridgeway Biologicals.
Production, Research & Development Sales, Service
IDT Biologika’s significant growth was fueled by the high demand for new vaccines to combat diseases around the globe. The company achieved sales of 240.9 million euros for fiscal year 2017 (preliminary figures). IDT annually invests around six percent of its revenue in research and development of its own proprietary products. In 2017 IDT employed approximately 1,915 people worldwide.
As a global manufacturer, IDT Biologika undergoes regular inspections by clients and independent regulatory agencies, such as the European Medicines Agency (EMA) and the U.S. Food & Drug Administration (FDA). IDT Biologika’s advanced production system positions the company among the world’s leading vaccine manufacturing corporations. Pioneering technologies for the production of new vaccines and pharmaceuticals underscores IDT’s commitment to set standards for pharmaceutical production, both now and in the future. IDT Biologika’s focus on customers and operational excellence has earned the company many international awards.
IDT Biologika is a member of the Klocke Group. Klocke Group companies are specialized in contract production and packaging of medications, vaccines and cosmetic products. A traditional, family-owned company, the Klocke Group employs a workforce of more than 2,200 people in Europe and the U.S. The group offers comprehensive services for the manufacture and packaging of pharmaceutical products at its eight production facilities.
For more information about the Klocke Group, visit: www.klocke.com